NCT06752850 - A Study to Investigate the Course of Synovial Hypertrophy in Patients With Haemophilia A on Efanesoctocog Alfa Prophylaxis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 19, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Haemophilia A (Moderate or Severe)Hemophilia, ClassicHaemophiliaHemophiliaClassic HemophiliaSynovial Hypertrophy

Interventions

DRUG

Efanesoctocog alfa

50 IU/kg once weekly, Intravenous injection

Trial Locations (10)

RECRUITING

Sobi Investigational Site, Milan

RECRUITING

Sobi Investigational Site, Naples

RECRUITING

Sobi Investigational Site, Rozzano

RECRUITING

Sobi Investigational Site, Oslo

RECRUITING

Sobi Investigational Site, Barcelona

RECRUITING

Sobi Investigational Site, Madrid

RECRUITING

Sobi Investigational Site, Seville

RECRUITING

Sobi Investigational Site, Valencia

RECRUITING

Sobi Investigational Site, Gothenburg

RECRUITING

Sobi Investigational Site, Malmo